Anders Research
Subscribe
Sign in
Share this post
Anders Research
Immix Biopharma: A Mid-To-Late Stage CAR-T Biotech Quietly Gaining Momentum
Copy link
Facebook
Email
Notes
More
Immix Biopharma: A Mid-To-Late Stage CAR-T…
Anders Research
Sep 19, 2023
1
Share this post
Anders Research
Immix Biopharma: A Mid-To-Late Stage CAR-T Biotech Quietly Gaining Momentum
Copy link
Facebook
Email
Notes
More
2024 Price Target: $13.96 (+422%)
Read →
Comments
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Share this post
Immix Biopharma: A Mid-To-Late Stage CAR-T…
Share this post
2024 Price Target: $13.96 (+422%)